UCB Pharma To Launch Keppra-Only Pregnancy Registry In January
This article was originally published in The Pink Sheet Daily
Executive Summary
Levetiracetam registry will allow the company to access pregnancy exposure data that could also be used to support follow-on products to treat epilepsy. Patients may self-register or enroll through their health care provider.